Name: Cognition Therapeutics, Inc. (CGTX) Balance Sheet
Creator: FinSpry

Cognition Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cognition Therapeutics, Inc. (CGTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	25.01	29.92	41.56	54.72	5.19
Cash & Short-Term Investments	25.01	29.92	41.56	54.72	5.19
Accounts Receivable	2.69	1.28	3.67	2.27	1.15
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.86	3.02	2.41	2.01	0.54
Total Current Assets	29.56	34.22	47.65	58.99	6.91
Non-Current Assets
Property, Plant & Equipment (Net)	0.68	0.94	1.05	0.15	0.21
Other Non-Current Assets	0.00	0.00	1.73	0.00	0.00
Total Non-Current Assets	0.68	0.94	2.78	0.15	0.00
Total Assets	30.23	35.16	50.43	59.14	7.12
Current Liabilities
Accounts Payable	1.98	3.70	3.22	4.17	2.00
Short-Term Debt	0.28	0.54	0.63	0.00	0.00
Accrued Liabilities	6.09	2.89	1.22	0.47	0.99
Deferred Revenue	1.07	1.70	1.70	0.75	0.00
Other Current Liabilities	7.62	0.54	0.63	1.19	0.25
Total Current Liabilities	11.14	10.17	7.80	7.86	3.25
Non-Current Liabilities
Long-Term Debt	0.34	0.52	0.70	0.00	12.85
Other Non-Current Liabilities	0.00	1.70	3.39	0.00	3.83
Total Non-Current Liabilities	0.34	0.52	2.38	0.00	0.00
Total Liabilities	11.48	10.69	10.18	7.86	19.93
Stockholders' Equity
Common Stock	0.06	0.03	0.03	0.02	0.00
Retained Earnings	-175.16	-141.19	-115.40	-94.00	-68.22
Accumulated Other Comprehensive Income	0.00	-0.20	-0.20	-0.20	-0.19
Additional Paid-in Capital	193.85	165.83	155.82	145.45	0.00
Shares Outstanding	59.85	32.17	28.99	22.23	0.00
Total Stockholders' Equity	18.75	24.47	40.25	51.27	-12.81
Total Liabilities & Equity	30.23	35.16	50.43	59.14	0.00